SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 14 filers reported holding SUMMIT THERAPEUTICS PLC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,806,000 | -32.7% | 150,000 | -38.0% | 0.18% | -33.5% |
| Q4 2017 | $2,683,000 | -11.5% | 242,113 | 0.0% | 0.26% | -58.8% |
| Q3 2017 | $3,031,000 | +127.2% | 242,113 | +106.7% | 0.64% | +93.9% |
| Q2 2017 | $1,334,000 | -14.6% | 117,113 | 0.0% | 0.33% | -29.6% |
| Q1 2017 | $1,562,000 | +55.9% | 117,113 | 0.0% | 0.47% | -41.6% |
| Q4 2016 | $1,002,000 | +5.0% | 117,113 | +11.3% | 0.80% | +114.2% |
| Q3 2016 | $954,000 | +7.1% | 105,261 | -6.6% | 0.37% | -2.4% |
| Q2 2016 | $891,000 | -34.2% | 112,676 | -4.4% | 0.38% | +88.2% |
| Q4 2015 | $1,355,000 | +1.8% | 117,841 | -7.8% | 0.20% | -77.7% |
| Q3 2015 | $1,331,000 | -1.7% | 127,841 | -0.2% | 0.91% | +131.5% |
| Q2 2015 | $1,354,000 | -12.6% | 128,157 | +2.5% | 0.39% | -30.5% |
| Q1 2015 | $1,549,000 | – | 125,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 212,018 | $2,349,000 | 0.28% |
| Granite Point Capital Management, L.P. | 242,113 | $2,683,000 | 0.26% |
| LANSDOWNE PARTNERS (UK) LLP | 1,596,666 | $17,691,000 | 0.16% |
| Point72 Asset Management, L.P. | 785,600 | $8,704,000 | 0.04% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 80,000 | $886,000 | 0.02% |
| AXA S.A. | 282,760 | $3,133,000 | 0.01% |
| Polar Capital LLP | 100,000 | $1,108,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 144,083 | $1,595,000 | 0.01% |
| First Eagle Investment Management, LLC | 194,900 | $2,159,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,000 | $554,000 | 0.00% |